Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01166464 · ClinicalTrials.gov registry record · NA

Examining a Text Message Intervention for Smoking Cessation

A NA study of Tobacco Use Disorder and Nicotine Dependence, sponsored by The Miriam Hospital.

Completed
Registry status
NA
Development phase
84
Enrollment target
1
Study location

NCT01166464 is a NA study of Tobacco Use Disorder and Nicotine Dependence that has completed, run by The Miriam Hospital. The registered enrollment target is 84 participants, below the 238-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01166464, a NA study of Tobacco Use Disorder and Nicotine Dependence, has completed, sponsored by The Miriam Hospital.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target
1
Study location

Study Summary

The primary goal of this study is to use qualitative interviews and focus groups to aid us in adapting a face-to-face smoking cessation intervention for delivery through text messaging. After design is completed, the intervention will be pilot tested with a sample of young adults (ages 18-35) who smoke. Final assessments will be conducted at 7 weeks (end of treatment) and both 3 and 6 month follow up.

Interventions

  • BEHAVIORAL Generic text messages
  • BEHAVIORAL text messaging for smoking cessation

Study Locations (1)

Rhode Island

  • The Miriam Hospital - Providence

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2009-07
Est. Completion 2012-10
Phase NA

Sponsor

The Miriam Hospital

136 total trials

What the Registry Record Tells You About NCT01166464

The ClinicalTrials.gov registry entry for NCT01166464 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 238-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (65% lower). The listed sponsor is The Miriam Hospital, which has 136 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Tobacco Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Generic text messages is the first listed.

NCT01166464 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT01166464 about?

NCT01166464 is a clinical study titled "Examining a Text Message Intervention for Smoking Cessation". The primary goal of this study is to use qualitative interviews and focus groups to aid us in adapting a face-to-face smoking cessation intervention for delivery through text messaging. After design is completed, the intervention will be pilot tested with a sample of young adults (ages 18-35) who sm...

What is the current status of trial NCT01166464?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2009-07. Estimated completion is 2012-10.

What conditions does trial NCT01166464 study?

This clinical trial studies the following conditions: Tobacco Use Disorder, Nicotine Dependence.

What interventions are being tested in trial NCT01166464?

The interventions under investigation include: Generic text messages (BEHAVIORAL), text messaging for smoking cessation (BEHAVIORAL).

Who is sponsoring clinical trial NCT01166464?

This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01166464 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.